Perry C. Siatis is VP & Secretary at AbbVie Inc. (ABBV). They have made 6 open-market trades across 1 company since 2023, most recently 2026-03-02.
CIK 0001951400
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABBV | 23,287 | $6.6M |
Shares reported on the most recent Form 4, priced at the 2026-03-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABBV | SELL | 2026-03-02 | 2026-03-03 | $234.39 | $4.4M | -5.9% | -10.6% | -8.8% |
| ABBV | SELL | 2026-02-25 | 2026-02-27 | $230.00 | $5.1M | -2.6% | -8.8% | -6.4% |
| ABBV | SELL | 2025-02-28 | 2025-03-04 | $208.06 | $7.9M | +2.3% | -2.6% | -9.7% |
| ABBV | SELL · 10b5-1 | 2025-02-20 | 2025-02-24 | $197.90 | $2.3M | +2.7% | -1.9% | -9.5% |
| ABBV | SELL · 10b5-1 | 2024-02-29 | 2024-03-01 | $177.39 | $3.5M | +0.8% | +1.4% | -12.4% |
| ABBV | SELL · 10b5-1 | 2024-02-23 | 2024-02-27 | $177.51 | $4.9M | -0.6% | +1.3% | -13.6% |
| ABBV | SELL | 2023-04-03 | 2023-04-05 | $160.00 | $563K | -0.8% | -7.9% | -14.4% |
| ABBV | SELL | 2023-03-01 | 2023-03-02 | $153.08 | $3.7M | -0.3% | +3.9% | -10.6% |
| ABBV | SELL | 2023-02-21 | 2023-02-22 | $151.03 | $2.2M | +2.9% | +4.7% | -5.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.